Watching the Trade Tea Leaves, Biotech M&A Monday & Coca-Cola CEO Exclusive

Dow Gains 580 Points, Honeywell CEO, Restaurant Brands CEO, And COVID-19 Index Update: The Dow rallied today despite fears over coronavirus surges across the U.S. and Jim Cramer is breaking down today's market moves. Then, as Honeywell moves to a software oriented portfolio, how could the new company perform in a new normal? CEO Darius Adamczyk checks in with Cramer to discuss how short-term COVID-19 challenges and long-term structural changes might impact the stock going forward. Then, Restaurant Brands CEO Jose Cil breaks down what reopening might look like for their brands- Burger King, Popeye's and Tim Hortons. Plus, Cramer's updating you on additions and changes to his COVID-19 index as pandemic-induced volatility continues to shake the market. by Mad Money w/ Jim Cramer

47 min listen

DOW Surges Over 500 Points, GSK CEO & Bioreference CEO: The market rallied today and Cramer is diving into the coronavirus developments and the impact on business. Then, an exclusive interview with GSK CEO, Emma Walmsley, on the announcement of the company’s historic collaboration with Sanofi to develop and produce a vaccine for COVID-19. And, Cramer goes off the carts to examine how the pandemic is affecting the defense industry. Plus, Dr. Jon Cohen, executive chairman of BioReference Laboratories, joins the program to discuss the state of drive-thru testing in New York and New Jersey and what it means for mass testing roll outs across the country. by Mad Money w/ Jim Cramer

47 min listen

Market Streak Snaps, Walmart and FedEx Messages to Investors, J&J's $8.9B Settlement 4/5/23: Carl Quintanilla and Jim Cramer discussed what's ahead for the markets one day after the Dow and S&P 500 snapped-four day win streaks. The anchors reacted to weaker-than-expected ADP jobs data, as well as comments from Cleveland Fed President Loretta Mester, who said the rate target needs to go above 5%. Two well-known nameshosting investor events Wednesday: Walmart reaffirmed full-year guidance and outlined a 5-year strategy for profitability, while FedEx hiked its dividend and announced plans to consolidate its operating units into one organization. Also in focus: Johnson& Johnson agrees to pay $8.9 billion to settle lawsuits that claim its talc products cause cancer, Apple's Tim Cook and Disney's Bob Iger to discuss China with U.S. lawmakers, why healthcare stocks are a bright spot, Cramer's three "trading camps." by Squawk on the Street

43 min listen

Markets Jump, Lulu Slumps, Jack Ma Cedes Control of Ant Group, Merck CEO "First on CNBC" 1/9/23: Carl Quintanilla, Jim Cramer and David Faber discussed the markets extending gains after a positive first week of 2023 for stocks. The anchors also explored woes for a pair of retailers: Shares of Lululemon and Macy's each down sharply on holiday quarter guidance. Carl, Jim and David reacted to Ant Group founder Jack Ma ceding control of the Chinese fintech giant, and the boost to shares of Alibaba, which owns a roughly 33% stake in Ant. Merck CEO Robert Davis offered his outlook for the pharma giant "First on CNBC" from the J.P. Morgan Healthcare Conference in San Francisco. Also in focus: Goldman Sachs reportedly set to begin layoffs, plus a look at the stocks rising more than 100% on M&A news. by Squawk on the Street

43 min listen

Biohaven CEO, Suntory Holdings CEO & Of The Charts 10/4/22: Stocks surged for a second straight day, with the major indices now more than 5% above their 2022 lows, and Jim Cramer is taking a closer look at what drove the averages higher. First, Biohaven closed its deal with Pfizer yesterday, selling its CGRP franchise to Pfizer for $11.6b, and Cramer is talking to Biohaven CEO Vlad Coric about the transaction and its pipeline of bipolar disorder and epilepsy treatments. Then, after a massive two-day rally, could this market rally keep running or is it due to run out of steam? Cramer's going Off The Charts to find out. Plus, Cramer's exclusive with Suntory Holdings CEO Tak Niinami. by Mad Money w/ Jim Cramer

45 min listen

Cisco CEO, ResMed CEO, Nestle CEO, & PVH CEO: After a continuous news flow on COVID-19 developments, Jim Cramer reacts to another plunge in the markets and looks on to the changing economic landscape heading into the second quarter. Then, Cramer talks with Cisco CEO, Chuck Robbins, about his company’s $250 million pledge to take on the coronavirus. And, Mick Farrell, the CEO of ResMed, joins Cramer to the discuss how his company is shifting gears to produce much needed ventilators for hospitals. Plus, Nestle CEO, Mark Schneider discusses his company’s efforts to keep their employees safe and shelves stocked around the world. by Mad Money w/ Jim Cramer

47 min listen

Good Rx CEO, Poshmark CEO & Dr. Eric Topol: The Dow closed down 260 points today and Jim Cramer’s giving you the rundown on how political blunders can pack a punch to the market. Next, with the launch of Amazon pharmacy and Walmart announcing its expansion of its pricing program, GoodRx CEO Doug Hirsch breaks down the pharmacy landscape and the company’s prospects amongst the competition. Then, with resale marketplaces growing in popularity, Cramer sits down with Poshmark CEO Manish Chandra to learn more about the company and its mission. Plus, Cramer is joined by Dr. Eric Topol to talk about COVID recovery efforts, the impact of variants, vaccines and more. by Mad Money w/ Jim Cramer

45 min listen

April 21, 2023 by The Top Line

22 min listen

Stocks Drop, Coronavirus Cases Escalate, New Terms for the T-Mobile, Sprint Deal: Carl Quintanilla, Jim Cramer and David Faber discuss the quick move in stocks to the downside. The number of new coronavirus cases escalates, fueling worries over a pronounced global economic slowdown. Shares of Deere surging after the heavy equipment maker beat estimates on the top and bottom line. The company says it sees signs of stabilization in the U.S. farm sector, and that the relaxation of trade tensions is imporving farmer confidence. David Faber’s exclusive reporting on T-Mobile, Sprint, as the operators announced amended terms of their merger agreement. Chewy pops on an upgrade to “outperform” from “sector perform” at RBC. Plus, HP adopts a “poison pill” in its fight to fend off Xerox. by Squawk on the Street

43 min listen

Rising Unemployment, Rising Investor Optimism: More than 5 million more Americans file for unemployment as the monthly total surpasses 22 million. Abbott Labs gets a boost on optimism over its coronavirus testing. Gilead Sciences gets a boost on optimism over its coronavirus treatment. Procter... by Motley Fool Money

39 min listen

Snap Shares Plummet, Dow Aims For 3-Week Win Streak, AmEx Beats Are Not Enough, Plus a Cisco CEO Exclusive. 10/21/22: Carl Quintanilla, Jim Cramer and David Faber led off the show by discussing shares of Snap losing more than a quarter of their value and dragging other social media stocks lower. The parent of Snapchat posted a quarterly revenue miss, hurt by a slowdown in digital ad spending. Hear what Cramer thinks about the stock -- and the company. The anchors also explored the markets on track for a positive week, including the Dow looking to extend its weekly win streak to three for the first time this year. Also in focus: American Express shares fall despite upbeat quarterly results and guidance, the U.S. reportedly mulling security reviews for some of Elon Musk's ventures - including his deal to buy Twitter, earnings from Verizon and Whirlpool, hospital stocks plunge, plus David's exclusive interview with Cisco CEO Chuck Robbins. by Squawk on the Street

43 min listen

Mad Money w/Jim Cramer 4/17/23: The averages rose to start the week and Jim Cramer is helping investors navigate the market's moves. First up, fresh off the announcement that Merck will buy Prometheus Biosciences for $11b, Cramer's talking to Merck CEO Rob Davis and Prometheus CEO Mark McKenna to dig deeper into what the deal will mean for investors and patients. Then, the S&P has climbed 8% this year, but is more upside ahead? Cramer's going Off The Charts to find out. Plus, Cramer's exclusive with InMode CEO Moshe Mizrahy. Mad Money Disclaimer by Mad Money w/ Jim Cramer

45 min listen

Markets, the Consumer, the Fed Effect, Bed Bath Plunges and Snap Surges 8/31/22: On a busy final trading day of August, Carl Quintanilla, Jim Cramer and David Faber discussed the markets in the midst of a three-day losing streak -- as Fed officials double down on saying they'll do what it takes on the interest rate front to battle inflation. The anchors explored the impact of slowing consumer and corporate demand on the likes of HP Inc., Chewy, PVH and Seagate. Also in focus: Shares of Bed Bath & Beyond down double-digits after announcing a turnaround plan including new financing commitments, store closings and job cuts, Snap's restructuring announcement gives the stock a boost, Goldman Sachs lifting COVID-19 requirements in most of its offices, and the FDA authorizes Pfizer and Moderna's updated booster shots targeting the Omicron variant. by Squawk on the Street

46 min listen

Markets Rally, Salesforce CEO, Perrigo CEO, & Biohaven CEO: The DOW rallied over 700 points today, and Jim Cramer is looking into which companies could be positioned to do well when the country opens back up for business. Then, the CEO of Salesforce, Marc Benioff joins Cramer to talk corporate responsibility and his company’s relief efforts in the face of the pandemic. Next, after pre-announcing its first quarter earnings results, Perrigo CEO, Murray Kessler, talks to Cramer about how the company is handling the surge in demand for generic over-the-counter self-care drugs. Plus, an exclusive with the CEO of Biohaven, Vlad Couric, on the launch his company’s new migraine treatment. by Mad Money w/ Jim Cramer

47 min listen

Stocks Bounce, Market Attempts to Recover from its Worst Drop in 2 Years, Mastercard’s Coronavirus Warning, Vaccine Coming?: Carl Quintanilla, Jim Cramer and David Faber breakdown the big swings in the market. Stocks jumping at the open as Wall Street tries to shrug off its worst day in two years. Experts still urging caution over the coronavirus, as cases outside of China continue to rise. Mastercard warns about the potential impact of the virus on its 2020 results, sending their shares down. The company also naming its Product Chief Michael Miebach as CEO, as Ajay Banga moves to Executive Chairman. Home Depot driving Dow gains, rising after earnings beat, the CEO says investments are paying off. Shares of Moderna skyrocketing after announcing it has shipped a coronavirus vaccine to U.S. government researches for study, with the first clinical trial expected by the end of April. Plus, David Faber breaks down HP’s earnings and what the company’s CEO is saying about Xerox’s proposal. by Squawk on the Street

43 min listen

RETAIL ROUT, TECH STOCKS RALLYING, VAPING CRACKDOWN: Carl Quintanilla, Jim Cramer and David Faber on the tough day for retail. Home Depot & Kohl’s sinking after cutting their outlooks and comps forecasts. Plus, Cramer’s take on the trade war why he’s saying the President wants ideological change in China. And vaping crackdown. California & Los Angeles county suing JUUL Labs, alleging the brand targeted young people through advertising and failed to give warnings about the health risks. by Squawk on the Street

43 min listen

GE CEO, Chipotle CEO, RingCentral CEO, & Okta CEO: After a volatile day on Wall Street, Jim Cramer takes you through Thursday’s financial news including oil’s best day ever and 6.6 million jobless claims. Next, Cramer talks with GE CEO, Larry Culp, on his efforts to guide the company through economic uncertainty while continuing to support the production of critically needed ventilators. Then, CEO Todd McKinnon of Okta, a Cramer family-fave, joins the program to discuss cloud-based security and the company’s plans for expansion. And, Chipotle CEO, Brian Niccol, gives insight on the company’s investment in delivery services and commitment to its employees and the nation’s healthcare workers. Plus, fresh off the launch of their new video service software, RingCentral CEO, Vlad Shmunis, goes one-on-one with Cramer about the company’s face off against Zoom and Cisco in the rapidly growing videoconferencing space. by Mad Money w/ Jim Cramer

47 min listen

Game Plan, Anaplan CEO, Biohaven Pharma CEO, & Centene CEO: Despite a phase one trade deal with China, the Dow remained steady today, rising only 3 points, and Jim Cramer’s giving you his Game Plan to navigate next week on Wall Street. Then, Anaplan CEO Frank Calderoni sits down to talk about the stock’s recent roar, up 90% for the year, and where the company is headed from here. Then, Dr. Vlad Coric, CEO of Biohaven Pharmaceuticals is in the Mad Money studio to talk about what’s in the company’s pipeline and what it means for the company’s future. And, what should you make of the managed care company’s heading into 2020? Cramer’s talking with Centene’s CEO, Michael Neidorff, to discuss the stock’s recent decline how you should interpret the company’s new guidance and its acquisition of WellCare. by Mad Money w/ Jim Cramer

43 min listen

Goodyear CEO, David Faber & Souring On Sweetgreen? 06/21/22: The Dow surged over 600 points, with the S&P and Nasdaq also rising, and Jim Cramer is bringing you up to speed on the market action that drove the indices higher. First, Goodyear CEO Richard Kramer joins CNBC's Cramer to talk about the company's latest innovations, supply chain and more. Then, Cramer's exclusive with CNBC’s David Faber on his new documentary, ExxonMobil At The Crossroads. Plus, Cramer explains the importance of price target cuts by using recent IPO Sweetgreen as a case study. by Mad Money w/ Jim Cramer

44 min listen

Learning to Love Big Pharma by Prognosis: Losing it

13 min listen

Domino's CEO, Inovio Pharmaceuticals CEO, & Digging Into UNH: Fresh off the company's top and bottom line beat, Cramer's checking in with the CEO of Domino's Pizza to learn more about how the company's delivering in a new environment. Then, after learning that Inovio Pharmaceuticals was one of the most-bought stocks on Robinhood in March, Cramer's talking to the company's CEO to learn more about its path towards finding a vaccine for COVID-19. Plus, Cramer's breaking down UnitedHealth Group's recent earnings to see if there are any insights investors should use to help in building their thesis. by Mad Money w/ Jim Cramer

47 min listen

Rallying Into the Fed Decision, Pfizer Slides On Guidance, Tesla Recalls 2 Million Vehicles 12/13/23: Carl Quintanilla, Jim Cramer and David Faber discussed stock markets in the midst of a four-day win streak andat their highest levels of the year, as investors await Wednesday's Fed decision. Pfizer shares tumble in reaction to 2024 guidance coming in below analysts' forecasts. The anchors explored the lackluster performance of the drugmaker's stock over the past 25 years -- and reacted to comments from Ken Langone: The billionaire told CNBC he believes Eli Lilly will become the first trillion-dollar pharma company. Also in focus: Tesla recalls more than two million vehicles due to autopilot software issues, Faber Report: U.S. Steel sale update. Squawk on the Street Disclaimer by Squawk on the Street

43 min listen

Markets and the Earnings Barrage, UPS' Message vs. FedEx's View and Raytheon's CEO Talks Earnings and Defense 10/25/22: Carl Quintanilla, Jim Cramer and David Faber explored market reaction to a deluge of quarterly results from the likes of General Electric, 3M, Coca-Cola and General. They discussed UPS rising on earnings and compared what the company's CEO said about the road ahead to what FedEx's CEO told CNBC last month about being "headed for a recession." Raytheon Technologies Chairman & CEO Greg Hayes joined the program to discuss the defense company's quarterly results and outlook in wake of the Russia-Ukraine conflict. Also in focus: Chinese tech stocks gain one day after tumbling, playing big tech ahead of Microsoft and Alphabet's after-the-bell earnings, and grill maker Weber surges on news of a buyout bid. by Squawk on the Street

43 min listen

Market Volatility Breakdown, Abbott's Top Brass, SAP Co-CEO, and Cloudflare CEO: In the face of growing unemployment and a worsening situation in New York City, Jim Cramer breaks down another day of markets rallying and the need for medical breakthroughs in a time of growing volatility. Then, Abbott's outgoing CEO, Miles White, and incoming CEO, Robert Ford, join Cramer to discuss their company's groundbreaking point-of-care COVID-19 test. Also, an exclusive with SAP’s new co-CEO, Jennifer Morgan, and her company's effort to assist the millions around the globe now working remotely. Plus, Cramer discusses the growing need for cybersecurity with Cloudflare CEO, Matthew Prince. by Mad Money w/ Jim Cramer

47 min listen

Yields and the Market Slump, Dimon on Rates, Pres. Biden and the UAW Strike 9/26/23: Carl Quintanilla, Jim Cramer and David Faber discussed the stock market under pressure: Higher yields in the spotlight amid Fed rate hike expectations. Cramer explained why the 20-year bond yield should be on investors' radar. The anchors reacted to what JPMorgan Chase CEO Jamie Dimon told CNBC about the road ahead for rates. Also in focus: President Biden's trip to Michigan to join UAW members on the picket lines, new developments surrounding AI, Apple senior executive Eddy Cue to take the stand in the Google antitrust trial, the market action involving makers of obesity drugs. Squawk on the Street Disclaimer by Squawk on the Street

42 min listen

Molson Coors CEO, Affirm CEO, Micron Technology CEO & Diamondback CEO 5/12/22: The Dow dropped in its sixth consecutive day of losses and Jim Cramer is guiding investors toward areas of opportunity. First, Molson Coors Beverage Company CEO Gavin Hattersley talks to Cramer about his company’s quarter results and new products. Then, Affirm soared after earnings and CEO Max Levchin discusses company partnerships, earnings, guidance and more. Next, Micron Technology CEO Sanjay Mehrotra gives Cramer a recap of the company's Investor Day. Plus, Diamondback Energy's CEO. by Mad Money w/ Jim Cramer

45 min listen

Nextdoor CEO, GSK Investor Day Preview & CNH Industrial CEO: The Dow rose 69 points today and Jim Cramer’s giving investors an update on where the market's headed as it bounces back from its recent declines. Then, Nextdoor CEO Sarah Friar talks about the launch of the app's new COVID-19 vaccine map and how the company is impacting communities. Next, Cramer’s giving you the lowdown on British pharma giant GlaxoSmithKline ahead of its investors day event tomorrow to let shareholders know what they should be looking out for. And, after announcing its purchase of Raven Industries, CNH Industrial CEO Scott Wine checks in with Cramer to learn more about the acquisition. by Mad Money w/ Jim Cramer

44 min listen

Reaction to the Fed's Pause and Rate Hike Signals, Cava CEO on IPO 6/15/23: Jim Cramer and David Faber explored the Fed's decision to stand pat on interest rates after ten consecutive hikes -- and signal that more tightening could be in the cards. Jim highlighted the connection between housing and inflation. What does it all mean for the markets? The anchors also discussed Cava going public and what's at stake for both the IPO market and the Mediterranean fast-casual restaurant chain. Cava CEO Brett Schulman joined Jim and David at Post 9 for a "First on CNBC" interview. Also in focus: Tesla snaps its record 13-day win streak, Lennar rises on earnings, an update on the FTC vs. Microsoft and Activision, an unexpected jump in May retail sales, Blackrock CEO Larry Fink's take on AI. Squawk on the Street Disclaimer by Squawk on the Street

44 min listen

Finding Opportunities in the Market Sell-Off, Corning’s Vaccine Effort, The Day Trader Effect: With the Dow falling more than 5% in its worst drop since mid-March, one trader tells us which names he’s cherry picking amid the sell-off. And the CEO of Corning joins to discuss how his company is joining the fight to find a coronavirus vaccine as biotech companies make big advances in potential treatments. Plus, we take a look at the effect the surge in day trading has had on the market and whether it spells more froth ahead. by The Exchange

47 min listen

Hologic CEO, Agua Media CEO & Digging Deeper Into Permian Resources 10/3/22: The Dow surged over 700 points, with all three averages starting Q4 with strong gains, and Jim Cramer is laying out what drove the market higher and if the market's fundamentals can keep the rally going. Then, as Breast Cancer Awareness month kicks off, Cramer sits down with women's health company Hologic. Then, Cramer's digging deeper into recent IPO Permian Resources to see if this Permian basin play could bring profits to your portfolio. Plus, Cramer's exclusive with Agua Media CEO Rick Sanchez. by Mad Money w/ Jim Cramer

44 min listen

Discover this podcast and so much more

Watching the Trade Tea Leaves, Biotech M&A Monday & Coca-Cola CEO Exclusive

Watching the Trade Tea Leaves, Biotech M&A Monday & Coca-Cola CEO Exclusive

Description

Titles in the series (100)

More Episodes from Squawk on the Street

Related podcast episodes